glycopyrrolate 0.4 MG in 2 ML Injection
- RxCUI
- 1731590
- RxNorm name
- glycopyrrolate 0.4 MG in 2 ML Injection
- Display name
- glycopyrrolate 0.4 MG in 2 ML Injection
- Full name
- glycopyrrolate 0.4 MG in 2 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02541cfd-b209-49b9-a73f-13ef18dce06d | 2026-05-20 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Gland Pharma Limited | d670bd26-8a44-44be-90e1-107d4c380233 | 2026-04-28 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Sagent Pharmaceuticals | 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2026-04-20 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Sandoz Inc | cb1ae370-ec4f-4114-9860-8f736f72b545 | 2026-04-01 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Lifestar Pharma LLC | 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | 2026-03-25 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2025-12-01 | Warnings, Adverse reactions | 1731590 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 2972f22e-378c-450b-8869-1354a9bd0ffc | 2025-11-30 | Warnings, Adverse reactions | 1731590 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | 2025-11-30 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | 2025-11-03 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Accord Healthcare, Inc., | 871797f0-697a-4a29-a37b-d06219e8f266 | 2025-10-17 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3f2b4281-55f3-43e3-e063-6294a90a56ba | 2025-09-18 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Alembic Pharmaceuticals Inc. | 327f8a9e-7730-4f38-a7aa-fbddebddf173 | 2025-08-26 | Warnings, Adverse reactions | 1731590 |
| GLYRX-PF | GLYCOPYRROLATE | Exela Pharma Sciences, LLC | 2189f3f5-39dc-4e85-b7c6-9515ded59686 | 2025-07-23 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | ccafb5c2-86dd-4bb2-883a-c13e3171227c | 2024-10-14 | Warnings, Adverse reactions | 1731590 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Somerset Therapeutics, LLC | 48cfbd5a-b133-4720-9bd7-65296064ea3c | 2024-08-31 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | American Regent, Inc. | 62267afe-1a73-4623-984e-646db590ec5b | 2024-02-07 | Warnings, Adverse reactions | 1731590 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | c4c3be3a-ea28-864f-e053-2a95a90a701a | 2024-01-30 | Warnings, Adverse reactions | 1731590 |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 54458620-d888-4df6-ae4b-78c3dfed3423 | 2023-08-16 | Warnings, Adverse reactions | 1731590 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 12 | Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220127 |
| a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 12 | Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220127 |
| a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 12 | Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220127 |
| cb1ae370-ec4f-4114-9860-8f736f72b545 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 11 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260401 |
| cb1ae370-ec4f-4114-9860-8f736f72b545 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 11 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260401 |
| cb1ae370-ec4f-4114-9860-8f736f72b545 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 11 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260401 |
| 62267afe-1a73-4623-984e-646db590ec5b | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 11 | GLYCOPYRROLATE INJECTION, USP | 20240207 |
| 62267afe-1a73-4623-984e-646db590ec5b | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 11 | GLYCOPYRROLATE INJECTION, USP | 20240207 |
| 62267afe-1a73-4623-984e-646db590ec5b | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 11 | GLYCOPYRROLATE INJECTION, USP | 20240207 |
| bbab4cf1-0441-4fc4-9de9-e4117fa19faa | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 10 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20251201 |
| bbab4cf1-0441-4fc4-9de9-e4117fa19faa | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 10 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20251201 |
| bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 10 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20251201 |
| d5a18d74-0d40-46e2-aa0a-41d18609a536 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 10 | GLYCOPYRROLATE INJECTION, USP | 20220304 |
| d5a18d74-0d40-46e2-aa0a-41d18609a536 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 10 | GLYCOPYRROLATE INJECTION, USP | 20220304 |
| d5a18d74-0d40-46e2-aa0a-41d18609a536 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 10 | GLYCOPYRROLATE INJECTION, USP | 20220304 |
| 83d70378-011b-4ce3-e053-2991aa0a22be | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 9 | Glycopyrrolate Injection, USP Rx Only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20250918 |
| 83d70378-011b-4ce3-e053-2991aa0a22be | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 9 | Glycopyrrolate Injection, USP Rx Only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20250918 |
| 83d70378-011b-4ce3-e053-2991aa0a22be | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 9 | Glycopyrrolate Injection, USP Rx Only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20250918 |
| 871797f0-697a-4a29-a37b-d06219e8f266 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 7 | Glycopyrrolate Injection, USP | 20251017 |
| 871797f0-697a-4a29-a37b-d06219e8f266 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 7 | Glycopyrrolate Injection, USP | 20251017 |
| 871797f0-697a-4a29-a37b-d06219e8f266 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 7 | Glycopyrrolate Injection, USP | 20251017 |
| d670bd26-8a44-44be-90e1-107d4c380233 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 6 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260428 |
| d670bd26-8a44-44be-90e1-107d4c380233 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260428 |
| d670bd26-8a44-44be-90e1-107d4c380233 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 6 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260428 |
| 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 6 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260325 |
| 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260325 |
| 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 6 | These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20260325 |
| 02541cfd-b209-49b9-a73f-13ef18dce06d | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 6 | Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | 20251118 |
| 02541cfd-b209-49b9-a73f-13ef18dce06d | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 6 | Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | 20251118 |
| 02541cfd-b209-49b9-a73f-13ef18dce06d | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 6 | Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | 20251118 |
| 29618edf-39b0-022a-9875-9d865450d318 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 6 | GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220412 |
| 29618edf-39b0-022a-9875-9d865450d318 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 6 | GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220412 |
| 29618edf-39b0-022a-9875-9d865450d318 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 6 | GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220412 |
| 516cc4f8-3583-4405-ab66-29d4fcc56d05 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 6 | GLYCOPYRROLATE INJECTION, USP | 20220323 |
| 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 6 | GLYCOPYRROLATE INJECTION, USP | 20220323 |
| 516cc4f8-3583-4405-ab66-29d4fcc56d05 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 6 | GLYCOPYRROLATE INJECTION, USP | 20220323 |
| 2189f3f5-39dc-4e85-b7c6-9515ded59686 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 5 | These highlights do not include all the information needed to use GLYRX ® -PF safely and effectively. See full prescribing information for GLYRX ® -PF. GLYRX ® -PF (glycopyrrolate injection), for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20250723 |
| 2189f3f5-39dc-4e85-b7c6-9515ded59686 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 5 | These highlights do not include all the information needed to use GLYRX ® -PF safely and effectively. See full prescribing information for GLYRX ® -PF. GLYRX ® -PF (glycopyrrolate injection), for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20250723 |
| 2189f3f5-39dc-4e85-b7c6-9515ded59686 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 5 | These highlights do not include all the information needed to use GLYRX ® -PF safely and effectively. See full prescribing information for GLYRX ® -PF. GLYRX ® -PF (glycopyrrolate injection), for intravenous or intramuscular use Initial U.S. Approval: 1975 | 20250723 |
| 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 5 | 20250125 | |
| 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 5 | 20250125 | |
| 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 5 | 20250125 | |
| 327f8a9e-7730-4f38-a7aa-fbddebddf173 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 4 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20250826 |
| 327f8a9e-7730-4f38-a7aa-fbddebddf173 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 4 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20250826 |
| 327f8a9e-7730-4f38-a7aa-fbddebddf173 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 4 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20250826 |
| 54458620-d888-4df6-ae4b-78c3dfed3423 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 4 | Glycopyrrolate Injection, USP | 20230816 |
| 54458620-d888-4df6-ae4b-78c3dfed3423 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 4 | Glycopyrrolate Injection, USP | 20230816 |
| 54458620-d888-4df6-ae4b-78c3dfed3423 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 4 | Glycopyrrolate Injection, USP | 20230816 |
| 55c9c26b-d08f-488f-a07c-c0dbb794a667 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 4 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20210415 |
| 55c9c26b-d08f-488f-a07c-c0dbb794a667 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 4 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20210415 |
| 55c9c26b-d08f-488f-a07c-c0dbb794a667 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 4 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20210415 |
| 55930f87-8964-43b1-b790-c1e6dd2602d2 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 3 | GLYCOPYRROLATE INJECTION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20260420 |
| 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 3 | GLYCOPYRROLATE INJECTION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20260420 |
| 55930f87-8964-43b1-b790-c1e6dd2602d2 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 3 | GLYCOPYRROLATE INJECTION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20260420 |
| 2972f22e-378c-450b-8869-1354a9bd0ffc | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 3 | Glycopyrrolate Injection, USP Rx only | 20251130 |
| 2972f22e-378c-450b-8869-1354a9bd0ffc | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 3 | Glycopyrrolate Injection, USP Rx only | 20251130 |
| 2972f22e-378c-450b-8869-1354a9bd0ffc | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 3 | Glycopyrrolate Injection, USP Rx only | 20251130 |
| 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 3 | Glycopyrrolate Injection, USP Rx only | 20251130 |
| 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 3 | Glycopyrrolate Injection, USP Rx only | 20251130 |
| 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 3 | Glycopyrrolate Injection, USP Rx only | 20251130 |
| ccafb5c2-86dd-4bb2-883a-c13e3171227c | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 3 | Glycopyrrolate Injection, USP | 20241014 |
| ccafb5c2-86dd-4bb2-883a-c13e3171227c | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 3 | Glycopyrrolate Injection, USP | 20241014 |
| ccafb5c2-86dd-4bb2-883a-c13e3171227c | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 3 | Glycopyrrolate Injection, USP | 20241014 |
| e620e03e-aab9-436f-93cb-9f717f25b89f | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 3 | GLYCOPYRROLATE INJECTION, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20230216 |
| e620e03e-aab9-436f-93cb-9f717f25b89f | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 3 | GLYCOPYRROLATE INJECTION, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20230216 |
| e620e03e-aab9-436f-93cb-9f717f25b89f | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 3 | GLYCOPYRROLATE INJECTION, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20230216 |
| 7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 3 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20211029 |
| 7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 3 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20211029 |
| 7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 3 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20211029 |
| 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 2 | GLYCOPYRROLATE INJECTION, USP Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20251103 |
| 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 2 | GLYCOPYRROLATE INJECTION, USP Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20251103 |
| 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 2 | GLYCOPYRROLATE INJECTION, USP Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20251103 |
| 48cfbd5a-b133-4720-9bd7-65296064ea3c | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 2 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20240831 |
| 48cfbd5a-b133-4720-9bd7-65296064ea3c | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 2 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20240831 |
| 48cfbd5a-b133-4720-9bd7-65296064ea3c | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 2 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20240831 |
| c4c3be3a-ea28-864f-e053-2a95a90a701a | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 2 | GLYCOPYRROLATE INJECTION, USP 0.4mg/2mL (0.2mg/mL) 2mL VIAL | 20240130 |
| c4c3be3a-ea28-864f-e053-2a95a90a701a | glycopyrrolate 0.4 MG per 2 ML Injection | SY | 2 | GLYCOPYRROLATE INJECTION, USP 0.4mg/2mL (0.2mg/mL) 2mL VIAL | 20240130 |
| c4c3be3a-ea28-864f-e053-2a95a90a701a | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 2 | GLYCOPYRROLATE INJECTION, USP 0.4mg/2mL (0.2mg/mL) 2mL VIAL | 20240130 |
| eaebb511-1738-4d11-b9bb-317a8d41316a | 2 ML glycopyrrolate 0.2 MG/ML Injection | SCD | 2 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20211222 |
| eaebb511-1738-4d11-b9bb-317a8d41316a | glycopyrrolate 0.4 MG in 2 ML Injection | PSN | 2 | Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20211222 |